LM-302
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for LM-302, covering 2024-09-19 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody [Phase 1, Phase 2]